Illumina Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones

2025.12.01 22:25

I'm PortAI, I can summarize articles.

Illumina Inc. (ILMN) shares fell 2.08% to $128.72 on Monday, ending a five-day winning streak, amid a broader market downturn. The S&P 500 Index dropped 0.53% and the Dow Jones Industrial Average fell 0.90%. Illumina's stock is 15.90% below its 52-week high of $153.06. Competitors like Labcorp, Charles River Laboratories, and Quest Diagnostics also saw declines.

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Illumina Inc. (ILMN) shed 2.08% to $128.72 Monday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 0.53% to 6,812.63 and Dow Jones Industrial Average falling 0.90% to 47,289.33. The stock's fall snapped a five-day winning streak. Illumina Inc. closed 15.90% short of its 52-week high of $153.06, which the company reached on January 14th. The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Labcorp Holdings Inc. (LH) fell 0.39% to $267.73, Charles River Laboratories International Inc. (CRL) fell 1.15% to $176.09, and Quest Diagnostics Inc. (DGX) fell 2.86% to $183.77. Data source: Dow Jones Market Data, FactSet. Data compiled December 1, 2025. This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. (END) Dow Jones Newswires 12-01-25 1725ET